Director/PDMR Shareholding

RNS Number : 8013S

GlaxoSmithKline PLC

21 March 2016

 

GlaxoSmithKline plc

(the "Company")

Notification of Transactions of Directors, Persons Discharging Managerial Responsibilities or Connected Persons

In accordance with DTR 3.1.4 R (1) (a) and (c), I give details of changes in the interests in the Company's Ordinary Shares of 25p each ("Ordinary Shares") for Sir Andrew Witty, a Director, following:

1.   the exercise of a nil cost option over 50,199 Ordinary Shares on 18 March 2016, granted on 28 February 2013, which vested on 28 February 2016 under the GlaxoSmithKline Deferred Annual Bonus Plan.  The Company delivered the net of tax value in shares being 26,605. The fair market value of an Ordinary Share at the point of exercise on 18 March 2016 was £13.82;

2.   the sale of 10,000 Ordinary Shares on 18 March 2016 at a price of £13.82 per Ordinary Share;

3.   the transfer on 18 March 2016 by way of gift of 3,000 Ordinary Shares to a Connected Person for nil consideration;

4.   a transfer on 18 March 2016 by way of gift of 3,000 Ordinary Shares to a Connected Person for nil consideration; and

5.   a disposal on 21 March 2016 by way of gift of 3,500 Ordinary Shares.

Following the above transactions, Sir Andrew's resulting shareholding in GSK Ordinary Shares is more than ten times his base salary, which is well in excess of his share ownership requirement of four times his base salary.

The Company and Sir Andrew were advised of these transactions on 21 March 2016.

V A Whyte

Company Secretary

21 March 2016

 

END

 

 

RDSQFLFLQXFBBBD